glp-1 therapy protein intake optimization research Dietary patterns and nutritional adequacy among adults with overweight or obesity treated with or dual GIP/GLP-1 receptor agonists- preliminary study | Journal of Translational Medicine Designing GLP-1 delivery: structural perspectives

Continuing the medication is not a failure, its evidence-based maintenance

The drugs robust demand contributed to Pfizers oncology portfolio growth, which saw a 30% increase in sales during the same period

Liraglutide (Saxenda/Victoza, Novo Nordisk) was the most common GLP-1 in the review and was included as the lone therapy in 16 studies and in combination with dulaglutide (Trulicity, Eli Lilly) in two studies

Our guides on foods to avoid on peptide therapy and best foods to eat on GLP-1 compounds provide specific dietary recommendations

Gavazzi G, Banfi B, Deffert C, Fiette L, Schappi M, Herrmann F, Krause KH